Literature DB >> 11223903

A mixed effects model for the analysis of ordinal longitudinal pain data subject to informative drop-out.

E Pulkstenis1, T R Ten Have, J R Landis.   

Abstract

We extend the model of Pulkstenis et al. that models binary longitudinal data, subject to informative drop-out through remedication, to the ordinal response case. We present a selection model shared-parameter approach that specifies mixed models for both ordinal response and discrete survival time to remedication. In this fashion, the random parameter present in both models completely characterizes the relationship between response and time to remedication inducing their conditional independence. With a log-log link function for both response and study 'survival', as well as specification of a log-gamma distribution for the random effect, we obtain a closed-form expression for the marginal log-likelihood of response and time to remedication that does not require approximation or numerical integration techniques. A data analysis is performed and simulation results presented which support the consistency of parameter and standard error estimates. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11223903     DOI: 10.1002/sim.696

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Practical considerations when analyzing discrete survival times using the grouped relative risk model.

Authors:  Rachel MacKay Altman; Andrew Henrey
Journal:  Lifetime Data Anal       Date:  2017-10-11       Impact factor: 1.588

2.  A random pattern mixture model for ordinal outcomes with informative dropouts.

Authors:  Chengcheng Liu; Sarah J Ratcliffe; Wensheng Guo
Journal:  Stat Med       Date:  2015-04-20       Impact factor: 2.373

3.  Two-part models for repeatedly measured ordinal data with "don't know" category.

Authors:  Ralitza Gueorguieva; Eugenia Buta; Meghan Morean; Suchitra Krishnan-Sarin
Journal:  Stat Med       Date:  2020-09-09       Impact factor: 2.373

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.